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The high reinduction rate may result
from (1) avoidance of drug resistance, (2)
early diagnosis ofrelapse or (3) positive effect
of immunotherapy or a combination of these
factors.
IMMUNE COMPETENCE IN COLON
CANCER: RELATIONSHIP OF PRE-
TREATMENT TESTS TO DIAGNOSIS
AND TUMOUR STAGE. A. M. MANDER,
P. M. BOLTON, R. H. WHITEHEAD, R. G.
NEWCOMBE and L. E. HUGHES, Department
of Surgery, Welsh National School of Medi-
cine, Cardiff.
A spectrum of immunological tests was
performed to assess cellular and humoral
immunity in 40 patients with colon cancer.
Controls had suspected cancer but proved to
have benign disease.
The tests employed were measurements of
peripheralwhitecellcount, lymphocyte count,
serum immunoglobulin levels, lymphocyte
response to PHA, DNCB response, and the
Montoux test. Results were correlated with
diagnosis and tumour stage. The colon
cancer patients had both absolute and
relative lymphocytopaenia. Serum IgM and
IgA levels were significantly raised in the
cancer group and were highest in the patients
with distant spread. No difference in
lymphocyte response to PHA was observed.
DNCB and Mantoux responses were markedly
depressed in the cancer group even in patients
with early cancer. Discrimination between
benign and malignant conditions was not
greatly improved by using the tests in
combination.
HOST TUMOUR RELATIONSHIP IN
STOMACH CANCER-CORRELATION
OF HISTOLOGICAL CRITERIA WITH
TESTS OF IMMUNE COMPETENCE.
A. M. MANDER, C. A. MORGAN, E. W. OWEN,
J. ZLOSNICK and L. E. HUGHES, Welsh
National School of Medicine, Cardiff.
The current prospective study involves
multifactorial computer analysis of 50
stomach cancer patients who have been
assessed from two separate approaches: the
first by preoperative estimation of host
immune competence, measuring lymphocyte
response to phytohaemagglutinin, peripheral
lymphocyte count, serum immunoglobulin
levels, Mantoux response and dinitrochloro-
benzene skin testing, and the second approach
by histological examination of tumour and
lymph nodes for evidence of cellular and
humoral immune response.
Correlation of the two sets of data with
each other and with clinical tumour staging
has given a broad view of host tumour
interaction in stomach cancer. The results
will allow an assessment of whether histo-
logical parameters of cellular and humoral
immunity correlate with results obtained by
immunosurveillance tests, and which ofthese
is most relevant to the clinical outcome ofthe
disease.
HUMORAL IMMUNITY IN HUMAN
LUNG NEOPLASIA. M. DAWSON and
M. MOORE, Paterson Laboratories, Man-
chester.
Sera from patients with carcinoma of the
lung were examined for evidence of humoral
immunity towards allogeneic lung carcinoma
cells in short-term culture.
Microcytotoxicity assays were used to
investigate: (a) complement dependent cyto-
toxicity; (b) serum mediated cellular cyto-
toxicity and (c) " blocking" activity of sera
towards leucocytes obtained from patients
with lung carcinoma.
The incidence of complement dependent
cytotoxic antibody to the sera was low, only
3/18 (17%) sera giving positive reactions. A
higher proportion 8/18 (44%) of the same
sera were found toiinduce cellularcytotoxicity
against lung carcinoma cells in leucocytes
obtained from healthy donors, while " block-
ing" activity towards lung cancer patients'
leucocytes was found in 10/18 (56%) sera.
The latter phenomenon was not specific since
5/7 (71%) sera from patients with unrelated
cancers also reduced the cytotoxicity of
leucocytes from lung cancer patients for
cultured lung carcinoma cells. The impli-
cations ofthese findings for the interpretation
of in vitro cytotoxicity tests in the human
allogeneic context are to be examined.
MACROPHAGE MIGRATION INHIBI-
TION AND IMMUNOGLOBULIN PRO-
DUCTION BY HODGKIN'S DISEASE
(HD) BIOPSY SPECIMENS IN VITRO.
D. B. JONES, S. V. PAYNE, J. L. SMITH, and
D. H. WRIGHT, Department of Experimental
Pathology, Southampton University.